skip to the main content
Contact Us
Go Search
Go Search Menu

Ustekinumab

Measuring Ustekinumab drug concentrations in patients being treated with Ustekinumab for chronic autoimmune and inflammatory conditions

Therapeutic Drug Monitoring (TDM) is to optimize biologic treatment for an individual patient. AFIAS Ustekinumab allows for reliable measurement of Ustekinumab drug levels using just a small amount of human serum, plasma, or whole blood, delivering results in 10 minutes. This allows clinicians to confirm the drug levels of Ustekinumab immediately before the next administration.

  • CE

Available Instruments

AFIAS-1 AFIAS-3 AFIAS-6 AFIAS-10

About Using Reagent

  • Sample Types

    Whole blood, Serum, and Plasma

  • Reaction Time

    10 mins

  • Detection Range

    0.5-20 μg/mL

  • Intended Use

    Quantitative determination of free Ustekinumab in human whole blood/serum/plasma

In Your Medical Field

AFIAS Ustekinumab measures Ustekinumab drug levels in patients' blood, using whole blood, serum, or plasma samples. This allows clinicians to obtain TDM results within just 10 minutes. It provides valuable insights into patients’ response to the treatment of Ustekinumab.